We are live on
!
Find out more
CBN
Cadence Bank NA Portfolio holdings
AUM
$16.1M
1-Year Est. Return
6.53%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
-6.53%
3 Year Est. Return
+33.27%
5 Year Est. Return
+59.34%
10 Year Est. Return
–
AUM
$264M
AUM Growth
+$44.9M
(+20%)
Cap. Flow
+$36.9M
Cap. Flow
% of AUM
13.96%
Top 10 Holdings %
Top 10 Hldgs %
33.09%
Holding
191
New
49
Increased
45
Reduced
72
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.29M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.75M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.63M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.55M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$940K |
| 2 |
Medtronic
MDT
|
+$382K |
| 3 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$330K |
| 4 |
AZ
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
|
+$262K |
| 5 |
Qualcomm
QCOM
|
+$244K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.14% |
| 2 | Energy | 15.01% |
| 3 | Healthcare | 12.87% |
| 4 | Technology | 9.15% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
GSK
GSK
$104B
| – | – |
-4,369
| Closed | -$236K |
|
177
ING
ING
$99.8B
| – | – |
-11,280
| Closed | -$196K |
|
178
iShares MBS ETF
MBB
$38.9B
| – | – |
-2,205
| Closed | -$235K |
|
|
179
Medtronic
MDT
$109B
| – | – |
-4,301
| Closed | -$382K |
|
|
180
Invesco FTSE RAFI US 1000 ETF
PRF
$9.79B
| – | – |
-15,950
| Closed | -$330K |
|
|
181
Qualcomm
QCOM
$155B
| – | – |
-4,405
| Closed | -$244K |
|
182
J.M. Smucker
SJM
$12.7B
| – | – |
-1,761
| Closed | -$208K |
|
183
Zimmer Biomet
ZBH
$18.2B
| – | – |
-1,738
| Closed | -$217K |
|
|
DD
184
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-11,642
| Closed | -$940K |
|
|
AZ
185
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| – | – |
-13,351
| Closed | -$262K |
|
|
SCO
186
DELISTED
SCOR ADS (ORD 1/10 SH FRF 25 P.V.)
SCO
| – | – |
-21,210
| Closed | -$84K |
|
|
AND
187
DELISTED
ANDREA ELECTRONICS CORP
AND
| – | – |
-40,000
| Closed | -$2K |
|
Similar funds
SVGI
AEPV
UMC
WL
AGDR
FRI
LI
CA
Cadence Bank NA's Q3 2017 Portfolio in Review
As of Q3 2017, Cadence Bank NA held 191 positions worth $264M, up 20% from $219M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Cadence Bank NA deployed $36.9M of net new capital in Q3 2017, opening 49 new positions and adding to 45 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 77,569 shares worth $3.37M.
By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, down from 18% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $215K trimmed.
- Cadence Bank NA's largest Q3 2017 buy was Vanguard FTSE Developed Markets ETF: 77,569 shares worth $3.37M.
- Cadence Bank NA added most to DuPont de Nemours in Q3 2017, an estimated $920K increase.
- Cadence Bank NA's biggest Q3 2017 reduction was Merck, cutting an estimated $215K.
- Cadence Bank NA fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $940K.
- Cadence Bank NA's ten largest holdings make up 33% of its $264M portfolio in Q3 2017.
- Cadence Bank NA opened 49 new positions and closed 17 in Q3 2017.
- Cadence Bank NA's portfolio value rose 20% quarter-over-quarter to $264M.
Based on Cadence Bank NA's 13F filing for Q3 2017, filed 27 Oct 2017.